The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study
NCT05258643
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Complement Abnormality
Peripheral Blood Mononuclear Cells
Covid19
Interventions
OTHER:
Blood analysis
Sponsor
Universitair Ziekenhuis Brussel